Article
CRISPR activation of the ribosome-associated quality control factor ASCC3 ameliorates fragile X syndrome phenotypes in mice.
Science translational medicine - 8 Oct 2025
Geng Ji, Wang Xiying, Pan Jie, Khan Danish, Pimcharoen Sopida, Zhang Yongjie, Mosammaparast Nima, Hirose Susumu, Petrucelli Leonard, Brandman Onn, Qi Lei S, Lu Bingwei
Abstract excerpt
Loss of fragile X messenger ribonucleoprotein (FMRP) causes fragile X syndrome (FXS), an inherited neurodevelopmental disorder resulting in intellectual disability and autism spectrum disorder; however, the molecular function of FMRP remains uncertain. Here, using cell lines and fibroblasts and induced pluripotent stem cell-derived neurons from healthy individuals and patients with FXS, we showed that FMRP...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
